AbaR4-type resistance island including the blaOXA-23 gene in Acinetobacter nosocomialis isolates

Antimicrob Agents Chemother. 2012 Aug;56(8):4548-9. doi: 10.1128/AAC.00923-12. Epub 2012 Jun 11.

Abstract

This study reports for the first time the AbaR4-type resistance island with the bla(OXA-23) gene in two carbapenem-resistant A. nosocomialis isolates from South Korea and Thailand.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter / drug effects*
  • Acinetobacter / genetics*
  • Acinetobacter / isolation & purification
  • Acinetobacter Infections / drug therapy*
  • Acinetobacter Infections / microbiology
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Carbapenems / pharmacology*
  • Carbapenems / therapeutic use
  • Cross Infection / microbiology*
  • Drug Resistance, Multiple, Bacterial / genetics
  • Humans
  • Microbial Sensitivity Tests
  • Republic of Korea
  • Thailand
  • beta-Lactamases / biosynthesis
  • beta-Lactamases / genetics*

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • beta-lactamase OXA-23
  • beta-Lactamases